PerkinElmer expands in vivo instruments portfolio

PerkinElmer, Inc. has announced the expansion of its in vivo imaging portfolio with the launch of the Vega imaging system, a first-of-its kind ultrasound platform that combines hands-free, automated technology with high-throughput capability to accelerate non-invasive research & drug development studies of cancer, liver & kidney disease, cardiology & more. PerkinElmer is one of the leading providers of preclinical imaging systems spanning multiple modalities across ultrasound, optical & microCT, including the widely adopted IVIS optical imaging platform. The Vega system eliminates challenges associated with conventional handheld ultrasound systems through the use of two automated transducers located below the imaging stage. This innovative design results in easy-to-use technology which can be operated without a dedicated sonographer, while producing more consistent results compared to traditional ultrasound systems.